For SLPs

Hypophonia and Hypokinetic Dysarthria: Assessing Parkinson's Speech (MPT, DDK, GRBAS)

Hypophonia affects most people with Parkinson's - and the person cannot hear it. How to quantify it in a speech evaluation: maximum phonation time, diadochokinesis, the GRBAS scale, voice impact - with a worked case and report language.

Clément
11 min readJuly 12, 2026

"Nobody can hear me anymore." Nine times out of ten, it is not the person with Parkinson's who says it - it is the spouse. Hypophonia, the reduced vocal loudness characteristic of Parkinson's disease, has a cruel property: the speaker hears themselves as normal, because the disease recalibrates their perception of their own loudness. They speak at 55 dB, experience it as 70, and accuse the family of going deaf.

That is exactly why the evaluation must be quantified. You do not convince someone to work on their voice with impressions. You convince them with a phonation time of 9 seconds where the benchmark expects 15, and a curve they can see.

In short: in parkinsonian hypophonia, self-report is structurally biased - the speaker hears themselves as normal. So the evaluation rests on external measures (MPT, DDK, reading rate) plus a perceptual rating that stays entirely yours. A gap between collapsed measures and low perceived impact is not noise: it is the finding.
The pathway at a glance: here is the voice & speech assessment built into the app, task by task, with a sample results screen (fictional data). The neighboring tabs show the cluttering and stuttering assessments - same mechanics.
Explore the 3 built-in assessments Beta · fictional sample data

Parkinson's Voice & Speech Assessment

6 tasks · ~35 min

MPT · GRBAS · diadochokinesis

The tasks, guided on screen

1Case history & voice complaint2Maximum phonation time /a/3Diadochokinesis PA-TA-KA4Calibrated reading5GRBAS rating6Voice impact questionnaire

What the results screen looks like - Fictional example: “Mr. R.”, 68, Parkinson's for 5 years, “nobody can hear me anymore”

Hypophonia and motor slowing, quantified

Measures computed on the audio, adjustable after playback

Maximum phonation time /a/9.2 sshort time: under 10 s (adult)
0 snorm 15–3030 s
Diadochokinesis PA-TA-KA3.9 syll/sadult benchmark 4.5–7.5
2 syll/snorm 4.5–7.58 syll/s
GRBASG2 R1 B2 A1 S1rated by you
Perceived voice impact24 / 40built-in questionnaire
DDK regularityirregulardecays across the trial
Next stepvocal projection + intonation
Measures pre-filled by the analysis engine Every value adjustable after playback Pre-drafted Word report Automatic T0 → T1 comparison
Run this assessment with a client (30 days free)

A clinical orientation aid, to be confirmed in consultation. No automatic diagnosis.


Hypophonia and hypokinetic dysarthria, briefly

Hypophonia is a neurologically based reduction of vocal intensity - the cardinal voice symptom of the hypokinetic dysarthria seen in Parkinson's disease, which affects the large majority of people over the course of the disease. It typically travels with monotone speech (reduced pitch variation), breathiness or roughness, paradoxical rate acceleration (festinating speech), and impaired self-perception: the person does not hear themselves speaking quietly.

That last point changes everything for assessment: self-report alone is structurally biased. External measures are mandatory.


In session: the evaluation, task by task

1. Case history and voice complaint

Who complains (the person or the family - the gap is itself a sign), since when, in which situations (phone, groups, noise), medication schedule and on/off fluctuations. Schedule the testing away from on/off extremes and note it in the report: measures only compare if conditions are reproducible at T1.

2. Maximum phonation time (MPT)

A sustained /a/ held as long as possible, best of three trials. A single adult reference: under 10 seconds = short time, worth exploring (values vary with age and sex, and no reference applies before age 13). A short time makes glottal closure and breath support the first leads to explore. The app times it on the audio - no more "roughly".

3. Diadochokinesis (PA-TA-KA)

The typical parkinsonian profile: slow, hypokinetic, decaying across the trial - or conversely an uncontrolled acceleration with articulatory undershoot. Tempo and regularity are measured automatically; DDK norms and interpretation are here.

4. Calibrated reading

A standard passage, rate measured in syllables per second, plus end-of-sentence accelerations - the signature of parkinsonian speech that reading reveals better than conversation. For reference values, see our speech rate norms guide.

5. The GRBAS scale

The reference perceptual rating (Grade, Roughness, Breathiness, Asthenia, Strain - each 0 to 3). It remains entirely yours: the app presents the audio and the grid side by side, stores your rating and brings it back at the next assessment. Automating GRBAS would make no clinical sense - the principle of the built-in assessments is to automate measurement, never judgment.

6. Voice impact questionnaire

Perceived handicap (a built-in voice impact scale) - often dissociated from the measures in Parkinson's, and that dissociation is information: low perceived impact with collapsed measures signals the self-perception deficit, and points therapy toward recalibration (learning to "speak too loud" in order to speak normally).


Six tasks that quantify parkinsonian speech
Six tasks that quantify parkinsonian speech

Worked case: “Mr. R.”, 68

Fictional case, realistic numbers - Parkinson's for 5 years, referred by the neurologist, complaint carried by his wife.

Swipe the table to see every column

TaskResultBenchmark
MPT /a/ (best of 3)9.2 sshort time under 10 s
DDK PA-TA-KA3.9 syll/s, irregular, decaying4.5 – 7.5 syll/s
Reading rate5.9 SPS with final accelerations4 – 5 SPS
GRBASG2 R1 B2 A1 S1clinician-rated
Perceived voice impact24 / 40moderate measure/perception dissociation

Report language:

"Maximum phonation time is short (9.2 s, under the 10 s adult reference), diadochokinesis is slow and irregular with within-trial decay, reading rate accelerates at phrase endings, in a context of moderate breathiness and roughness (G2 B2). The picture is consistent with hypokinetic dysarthria with hypophonia. Plan: loudness and vocal projection work with visual feedback, prosodic training, quantified home practice between sessions; re-evaluation at 3 months on the same tasks."

That last sentence is not decorative: "re-evaluation on the same tasks" is only feasible if tasks are standardized and measures stored. That is what the automatic T0 → T1 comparison is for.

Objective assessments. Visible home practice.

30-day free trial, no credit card. Always free for your clients.

Start the free 30-day trial

From assessment to therapy: closing the loop

The parkinsonian evaluation lands on a therapeutic paradox: the approaches with the strongest evidence (intensive loudness-based programs such as LSVT LOUD) demand daily, intensive practice, while reimbursed sessions are weekly. The workable answer is an equipped home program: the client practices with real-time visual feedback on loudness (the same analysis engine as the assessment), and you monitor the curves remotely.

And because parkinsonian speech declines slowly, the re-assessment becomes the pivot of long-term care: same tasks, automatic comparison, and a 12-month MPT/DDK curve that documents maintenance (or justifies intensification) better than any impression.

The app includes, on the same mechanics and the same client chart, a cluttering assessment protocol and a stuttering assessment by age - one tool, three pathways, useful for mixed caseloads.


FAQ - your questions about parkinsonian speech

What exactly is hypophonia?

A pathological reduction of vocal loudness of neurological origin - distinct from a weak voice caused by laryngeal lesions or habit. In Parkinson's disease it results from rigidity and hypokinesia applied to the respiratory and laryngeal systems, and comes with impaired self-perception: the person does not notice they are speaking quietly.

Why can't the person hear that they speak too quietly?

The disease alters sensorimotor calibration: a "normal" vocal effort now produces reduced loudness, but the internal feedback still reads as usual volume. Hence the value of objective visual feedback (decibels, curves) in both assessment and therapy: an external measure replaces the failing perception.

Can the GRBAS scale be automated?

No, and it should not be: it is a perceptual rating whose value rests on the trained clinical ear. What is worth automating around it: standardized recording, timing (MPT, DDK), storage of your ratings and their comparison across assessments.

How often should Parkinson's speech be re-assessed?

Every 3 to 6 months during active therapy, yearly in maintenance - adjusted to disease progression and medication changes. What matters most is comparability: same tasks, on/off state noted, measures stored.

Does this assessment replace an ENT or neurological workup?

No. Any dysphonia warrants laryngeal examination when in doubt, and the speech evaluation sits inside coordinated care (neurologist, ENT). The app produces measures and a structured report; diagnosis remains clinical and multidisciplinary.


Key takeaways

  • The person does not complain - the family does. Self-report is structurally biased by the disease.
  • The assessment rests on external measures: MPT (short time under 10 s), DDK, reading rate with final accelerations.
  • GRBAS does not get automated, and should not be. Automate measurement, never judgment.
  • Collapsed measures with low perceived impact means a self-perception deficit. Therapy then targets recalibration.
  • Note on/off conditions in the report. Without them, the T0 → T1 comparison is worthless.
  • General information only: it does not replace the advice of a speech-language pathologist or a doctor. Talk Slower is not a medical device.

    Updated August 16, 2026

    Clément, founder of Talk Slower
    I built Talk Slower after my own cluttering therapy. I wanted to create the tool my speech-language pathologist would have prescribed if it had existed: objective SPS measurement, at-home exercises, remote tracking. The app keeps evolving by staying close to speech-language pathologists.
    Clément, founder

    Try it with your patients

    Your patients practice at home with visual feedback, and you follow their sessions remotely.

    Start the free 30-day trial
    • 30-day trial, no credit card
    • Unlimited patients
    • Free for your patients